Does ALEMTUZUMAB Cause Multiple sclerosis relapse? 836 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 836 reports of Multiple sclerosis relapse have been filed in association with ALEMTUZUMAB (Campath). This represents 5.9% of all adverse event reports for ALEMTUZUMAB.
836
Reports of Multiple sclerosis relapse with ALEMTUZUMAB
5.9%
of all ALEMTUZUMAB reports
14
Deaths
391
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From ALEMTUZUMAB?
Of the 836 reports, 14 (1.7%) resulted in death, 391 (46.8%) required hospitalization, and 23 (2.8%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 836 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Urinary tract infection (746)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which ALEMTUZUMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET